English | Español
Patient Daily | Jan 23, 2026

Lilly outlines strategy for continued dominance in competitive obesity drug market
Patient Daily | Jan 23, 2026

AbbVie highlights oncology ambitions after RemeGen licensing deal at JPMorgan conference
Patient Daily | Jan 23, 2026

Researchers develop fast noninvasive technique for full-body 3D medical imaging
Patient Daily | Jan 23, 2026

AstraZeneca outlines strategies to achieve $80B revenue goal by 2030
Patient Daily | Jan 23, 2026

Study finds FDA-cleared device ineffective for reducing ADHD symptoms in children
Patient Daily | Jan 23, 2026

Study identifies key immune marker for early detection and management of transplant complications
Patient Daily | Jan 23, 2026

UTHealth Houston study finds unique gene disruptions in early-onset Alzheimer’s brains
Patient Daily | Jan 23, 2026

FDA requests removal of suicide warnings from Novo Nordisk and Lilly GLP-1 weight loss drugs

Trending
+ Pharmaceuticals
Patient Daily | Mar 22, 2026

BioMarin pauses dosing and enrollment in two Voxzogo studies after safety signal
+ Regulatory
Patient Daily | Mar 20, 2026

Neurosurgeon DiGiorgio on 340B: '340B also takes money from taxpayers and makes everyone’s health insurance more expensive'
+ Pharmaceuticals
Patient Daily | Mar 22, 2026

FDA rejects REGENXBIO’s Hunter syndrome therapy as Denali awaits decision on rival drug
+ Pharmaceuticals
Patient Daily | Mar 25, 2026

Revolution and Ascendis identified as top buyout targets amid speculation of industry mega-merger